No Data
Dr. Glasses: Report for the first quarter of 2025
Doctorglasses Chain (300622.SZ) achieved a net income of 30.1778 million yuan in the first quarter, a year-on-year increase of 20.54%.
On April 28, Glonghui reported that Doctorglasses Chain (300622.SZ) announced its first quarter report for 2025, during which the company achieved revenue of 0.326 billion yuan, a year-on-year increase of 10.22%; the net income attributable to shareholders of the listed company was 30.1778 million yuan, a year-on-year increase of 20.54%; the net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 27.4131 million yuan, a year-on-year increase of 19.51%, and the EPS was 0.17 yuan.
Doctorglasses Chain (300622.SZ): Application to issue convertible CSI Enterprise bond Index to unspecified objects has been accepted by the Shenzhen Stock Exchange.
On April 28, Gelonghui reported that Doctorglasses Chain (300622.SZ) announced that on April 27, 2025, it received a notice from the Shenzhen Stock Exchange (hereinafter referred to as "the Exchange") regarding the acceptance of the application documents for the issuance of convertible corporate bonds to unspecified objects by Doctorglasses Chain Co., Ltd. (Shenzhen Stock Review [2025] No. 59). The Exchange checked the application documents submitted by the company for the issuance of convertible corporate bonds to unspecified objects and found that the documents were complete, thus deciding to accept the application.
Doctorglasses Chain Co.,Ltd.'s (SZSE:300622) Market Cap up CN¥680m Last Week, Benefiting Both Retail Investors Who Own 47% as Well as Insiders
Dr. Glasses: 2024 Annual Report Summary
Dr. Glasses: 2024 Annual Report
Doctorglasses Chain Co.,Ltd.'s (SZSE:300622) 26% Dip In Price Shows Sentiment Is Matching Earnings
